Truist Financial
XGN icon

Truist Financial’s Exagen XGN Stock Holding History

Truist Financial’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,740
Closed -$67K – 2686
2022
Q2 		$67K Sell
11,740
-221
-2% -$1.29K ﹤0.01% 2565
2022
Q1 		$96K Sell
11,961
-289
-2% -$2.49K ﹤0.01% 2616
2021
Q4 		$142K Sell
12,250
-1,637
-12% -$19.2K ﹤0.01% 2647
2021
Q3 		$189K Sell
13,887
-550
-4% -$7.31K ﹤0.01% 2571
2021
Q2 		$216K Sell
14,437
-987
-6% -$15.1K ﹤0.01% 2561
2021
Q1 		$270K Buy
+15,424
New +$275K ﹤0.01% 2358

Other funds holding XGN

CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Truist Financial's XGN Position: Q3 2022 in Review

Truist Financial sold out of Exagen (XGN) in Q3 2022, closing a stake of 11,740 shares — an estimated $67K sold.

Truist Financial first reported a position in XGN in Q1 2021 and held it in 6 quarters. The position peaked at $270K in Q1 2021. 38 funds tracked by Wall St. Rank hold XGN as of Q3 2022.

  • Truist Financial reported no remaining Exagen position as of Q3 2022 after selling out during the quarter.
  • Truist Financial sold 11,740 Exagen shares in Q3 2022, an estimated $67K.
  • Truist Financial first reported a position in Exagen in Q1 2021 and held it in 6 quarters.
  • Truist Financial's Exagen position peaked at $270K in Q1 2021.
  • 38 funds tracked by Wall St. Rank held Exagen as of Q3 2022.

Based on Truist Financial's 13F filing for Q3 2022, filed 26 Oct 2022.